vs
科睿唯安(CLVT)与西蒙地产集团(ELS)财务数据对比。点击上方公司名可切换其他公司
科睿唯安的季度营收约是西蒙地产集团的1.6倍($617.0M vs $397.6M),西蒙地产集团同比增速更快(6.3% vs -6.9%),过去两年西蒙地产集团的营收复合增速更高(2.3% vs -0.3%)
科睿唯安是一家英美合资的上市分析服务企业,主要提供订阅制信息服务,覆盖文献计量、科学计量、商业与市场情报领域,同时为医药、生物科技行业提供专利、监管合规相关的竞争分析,也提供商标保护、域名与品牌保护服务,旗下Web of Science产品系列还负责计算学术期刊的影响因子。
西蒙地产集团是美国头部房地产投资信托企业,投资范围涵盖购物中心、奥特莱斯及社区生活中心等商业地产业态,是美国规模最大的购物中心持有方,总部位于印第安纳州印第安纳波利斯,截至2024年12月末共持有232处物业权益。
CLVT vs ELS — 直观对比
营收规模更大
CLVT
是对方的1.6倍
$397.6M
营收增速更快
ELS
高出13.3%
-6.9%
两年增速更快
ELS
近两年复合增速
-0.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $617.0M | $397.6M |
| 净利润 | $3.1M | — |
| 毛利率 | 66.8% | — |
| 营业利润率 | 6.7% | — |
| 净利率 | 0.5% | — |
| 营收同比 | -6.9% | 6.3% |
| 净利润同比 | 101.6% | — |
| 每股收益(稀释后) | $0.00 | $0.56 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
CLVT
ELS
| Q1 26 | — | $397.6M | ||
| Q4 25 | $617.0M | $373.9M | ||
| Q3 25 | $623.1M | $393.3M | ||
| Q2 25 | $621.4M | $376.9M | ||
| Q1 25 | $593.7M | $387.3M | ||
| Q4 24 | $663.0M | $372.3M | ||
| Q3 24 | $622.2M | $387.3M | ||
| Q2 24 | $650.3M | $380.0M |
净利润
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | $3.1M | $103.8M | ||
| Q3 25 | $-28.3M | $100.4M | ||
| Q2 25 | $-72.0M | $83.5M | ||
| Q1 25 | $-103.9M | $114.4M | ||
| Q4 24 | $-191.8M | $100.6M | ||
| Q3 24 | $-65.6M | $86.9M | ||
| Q2 24 | $-304.3M | $82.1M |
毛利率
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 66.8% | — | ||
| Q3 25 | 65.0% | — | ||
| Q2 25 | 67.2% | — | ||
| Q1 25 | 65.1% | — | ||
| Q4 24 | 65.7% | — | ||
| Q3 24 | 66.2% | — | ||
| Q2 24 | 67.2% | — |
营业利润率
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 6.7% | 26.5% | ||
| Q3 25 | 7.1% | 25.1% | ||
| Q2 25 | 1.1% | 22.3% | ||
| Q1 25 | -3.5% | 28.3% | ||
| Q4 24 | -9.4% | 27.2% | ||
| Q3 24 | 3.5% | 21.4% | ||
| Q2 24 | -36.9% | 21.5% |
净利率
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 27.8% | ||
| Q3 25 | -4.5% | 25.5% | ||
| Q2 25 | -11.6% | 22.2% | ||
| Q1 25 | -17.5% | 29.5% | ||
| Q4 24 | -28.9% | 27.0% | ||
| Q3 24 | -10.5% | 22.4% | ||
| Q2 24 | -46.8% | 21.6% |
每股收益(稀释后)
CLVT
ELS
| Q1 26 | — | $0.56 | ||
| Q4 25 | $0.00 | $0.52 | ||
| Q3 25 | $-0.04 | $0.50 | ||
| Q2 25 | $-0.11 | $0.42 | ||
| Q1 25 | $-0.15 | $0.57 | ||
| Q4 24 | $-0.27 | $0.51 | ||
| Q3 24 | $-0.09 | $0.44 | ||
| Q2 24 | $-0.46 | $0.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $329.2M | — |
| 总债务越低越好 | $4.3B | — |
| 股东权益账面价值 | $4.8B | $1.8B |
| 总资产 | $11.1B | $5.7M |
| 负债/权益比越低杠杆越低 | 0.89× | — |
8季度趋势,按日历期对齐
现金及短期投资
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | $329.2M | — | ||
| Q3 25 | $318.7M | — | ||
| Q2 25 | $362.6M | — | ||
| Q1 25 | $354.0M | — | ||
| Q4 24 | $295.2M | — | ||
| Q3 24 | $388.5M | — | ||
| Q2 24 | $376.4M | — |
总债务
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | $4.3B | $3.3B | ||
| Q3 25 | $4.4B | — | ||
| Q2 25 | $4.5B | — | ||
| Q1 25 | $4.5B | — | ||
| Q4 24 | $4.5B | $3.2B | ||
| Q3 24 | $4.6B | — | ||
| Q2 24 | $4.6B | — |
股东权益
CLVT
ELS
| Q1 26 | — | $1.8B | ||
| Q4 25 | $4.8B | $1.8B | ||
| Q3 25 | $4.9B | $1.8B | ||
| Q2 25 | $5.0B | $1.7B | ||
| Q1 25 | $5.0B | $1.7B | ||
| Q4 24 | $5.1B | $1.7B | ||
| Q3 24 | $5.5B | $1.4B | ||
| Q2 24 | $5.6B | $1.4B |
总资产
CLVT
ELS
| Q1 26 | — | $5.7M | ||
| Q4 25 | $11.1B | $5.7B | ||
| Q3 25 | $11.2B | $5.7B | ||
| Q2 25 | $11.4B | $5.7B | ||
| Q1 25 | $11.5B | $5.6B | ||
| Q4 24 | $11.5B | $5.6B | ||
| Q3 24 | $12.0B | $5.6B | ||
| Q2 24 | $12.1B | $5.6B |
负债/权益比
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 0.89× | 1.91× | ||
| Q3 25 | 0.90× | — | ||
| Q2 25 | 0.90× | — | ||
| Q1 25 | 0.90× | — | ||
| Q4 24 | 0.88× | 1.84× | ||
| Q3 24 | 0.84× | — | ||
| Q2 24 | 0.83× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $159.9M | — |
| 自由现金流经营现金流 - 资本支出 | $89.2M | — |
| 自由现金流率自由现金流/营收 | 14.5% | — |
| 资本支出强度资本支出/营收 | 11.5% | — |
| 现金转化率经营现金流/净利润 | 51.58× | — |
| 过去12个月自由现金流最近4个季度 | $365.3M | — |
8季度趋势,按日历期对齐
经营现金流
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | $159.9M | $571.1M | ||
| Q3 25 | $181.1M | $147.0M | ||
| Q2 25 | $116.3M | $131.3M | ||
| Q1 25 | $171.2M | $193.4M | ||
| Q4 24 | $141.3M | $596.7M | ||
| Q3 24 | $202.9M | $149.5M | ||
| Q2 24 | $126.2M | $143.1M |
自由现金流
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | $89.2M | $334.1M | ||
| Q3 25 | $115.5M | $75.7M | ||
| Q2 25 | $50.3M | $71.8M | ||
| Q1 25 | $110.3M | $148.2M | ||
| Q4 24 | $59.1M | $355.4M | ||
| Q3 24 | $126.3M | $91.1M | ||
| Q2 24 | $60.3M | $80.6M |
自由现金流率
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | 89.4% | ||
| Q3 25 | 18.5% | 19.3% | ||
| Q2 25 | 8.1% | 19.1% | ||
| Q1 25 | 18.6% | 38.3% | ||
| Q4 24 | 8.9% | 95.5% | ||
| Q3 24 | 20.3% | 23.5% | ||
| Q2 24 | 9.3% | 21.2% |
资本支出强度
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 11.5% | 63.4% | ||
| Q3 25 | 10.5% | 18.1% | ||
| Q2 25 | 10.6% | 15.8% | ||
| Q1 25 | 10.3% | 11.7% | ||
| Q4 24 | 12.4% | 64.8% | ||
| Q3 24 | 12.3% | 15.1% | ||
| Q2 24 | 10.1% | 16.5% |
现金转化率
CLVT
ELS
| Q1 26 | — | — | ||
| Q4 25 | 51.58× | 5.50× | ||
| Q3 25 | — | 1.46× | ||
| Q2 25 | — | 1.57× | ||
| Q1 25 | — | 1.69× | ||
| Q4 24 | — | 5.93× | ||
| Q3 24 | — | 1.72× | ||
| Q2 24 | — | 1.74× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLVT
| Academia Government Group | $312.3M | 51% |
| Re Occurring Revenues | $114.1M | 18% |
| Life Sciences And Healthcare Group | $98.3M | 16% |
| Transactional Revenues | $97.1M | 16% |
ELS
| Rental income | $339.0M | 85% |
| Other | $37.2M | 9% |
| Annual membership subscriptions | $18.3M | 5% |
| Membership upgrade revenue | $3.1M | 1% |